BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 12571201)

  • 1. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
    Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
    J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and feasibility of cardiac FDG SPECT following oral administration of Acipimox, a nicotinic acid derivative: Comparison of image quality with hyperinsulinemic euglycemic clamping in nondiabetic patients.
    Bax JJ; Visser FC; Poldermans D; Van Lingen A; Elhendy A; Boersma E; Sloof GW; Visser CA
    J Nucl Cardiol; 2002; 9(6):587-93. PubMed ID: 12466782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gated 99mTc-tetrofosmin and 18F-FDG studies: a comparison of single-acquisition and separate-acquisition protocols.
    Pagnanelli RA; Hanson MW; Turkington T; Coleman RE; Borges-Neto S
    J Nucl Med Technol; 2002 Dec; 30(4):175-8. PubMed ID: 12446750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability.
    Schinkel AF; Bax JJ; Valkema R; Elhendy A; van Domburg RT; Vourvouri EC; Bountioukos MA; Krenning EP; Roelandt JR; Poldermans D
    J Nucl Med; 2003 Jun; 44(6):877-83. PubMed ID: 12791813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging.
    Giorgetti A; Marzullo P; Sambuceti G; Di Quirico S; Kusch A; Landi P; Salvadori PA; Pisani P; L'abbate A
    J Nucl Cardiol; 2004; 11(2):142-51. PubMed ID: 15052245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nitrate augmented Tc-99m tetrofosmin gated SPECT imaging with FDG PET imaging for the assessment of myocardial viability in patients with severe left ventricular dysfunction.
    Raja S; Singh B; Rohit MK; Manohar K; Kashyap R; Bhattacharya A; Mittal BR
    J Nucl Cardiol; 2012 Dec; 19(6):1176-81. PubMed ID: 22872319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.
    Raja S; Mittal BR; Santhosh S; Bhattacharya A; Rohit MK
    Nucl Med Commun; 2014 Nov; 35(11):1156-61. PubMed ID: 25144559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
    Schaefer WM; Nowak B; Kaiser HJ; Koch KC; Block S; vom Dahl J; Buell U
    J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction.
    Schinkel AF; Poldermans D; Rizzello V; van Domburg RT; Valkema R; Elhendy A; Biagini E; Krenning EP; Simoons ML; Bax JJ
    J Nucl Med; 2006 Jan; 47(1):68-73. PubMed ID: 16391189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
    Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
    Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
    Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET.
    He W; Acampa W; Mainolfi C; Menna F; Sorrentino AR; Petretta M; Cuocolo A
    J Nucl Cardiol; 2003; 10(6):599-606. PubMed ID: 14668771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.
    Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Tonami N; Hisada K
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):195-202. PubMed ID: 15449050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT.
    Slart RH; Bax JJ; Sluiter WJ; van Veldhuisen DJ; Jager PL
    J Nucl Cardiol; 2004; 11(6):689-96. PubMed ID: 15592192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction.
    Rambaldi R; Poldermans D; Bax JJ; Boersma E; Valkema R; Elhendy A; Vletter WB; Fioretti PM; Roelandt JR; Krenning EP
    Am J Cardiol; 1999 Jul; 84(2):130-4. PubMed ID: 10426327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability.
    De Boer J; Slart RH; Blanksma PK; Willemsen AT; Jager PL; Paans AM; Vaalburg W; Piers DA
    Nucl Med Commun; 2003 Mar; 24(3):251-7. PubMed ID: 12612465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Irwan R; Sluiter WJ; Dierckx RA; de Boer J; Jager PL
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):716-23. PubMed ID: 16523309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of myocardial perfusion and viability using simultaneous 99mTc-tetrofosmin--FDG collimated SPECT.
    Fukuchi K; Katafuchi T; Fukushima K; Shimotsu Y; Toba M; Hayashida K; Takamiya M; Ishida Y
    J Nucl Med; 2000 Aug; 41(8):1318-23. PubMed ID: 10945521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of functional improvement of ischemic myocardium with (123I-BMIPP SPECT and 99mTc-tetrofosmin SPECT imaging: a study of patients with large acute myocardial infarction and receiving revascularization therapy.
    Seki H; Toyama T; Higuchi K; Kasama S; Ueda T; Seki R; Hatori T; Endo K; Kurabayashi M
    Circ J; 2005 Mar; 69(3):311-9. PubMed ID: 15731537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
    Slart RH; Bax JJ; de Boer J; Willemsen AT; Mook PH; Oudkerk M; van der Wall EE; van Veldhuisen DJ; Jager PL
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):972-9. PubMed ID: 15824927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.